Giant cell hepatitis with autoimmune hemolytic anaemia (GCH-AHA) is a rare and aggressive disease of infancy and may have fatal prognosis. It is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown. Immunosuppressive therapymay results in remission in mild forms while in severe forms, B cell depletion with rituximab can be an option. Liver transplantation may be a rescue treatment but relapse can occur in the graft.
L'epatite gigantocellulare associata ad anemia emolitica autoimmune
MAGGIORE, Giuseppe
Ultimo
2014
Abstract
Giant cell hepatitis with autoimmune hemolytic anaemia (GCH-AHA) is a rare and aggressive disease of infancy and may have fatal prognosis. It is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown. Immunosuppressive therapymay results in remission in mild forms while in severe forms, B cell depletion with rituximab can be an option. Liver transplantation may be a rescue treatment but relapse can occur in the graft.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
GCH-AHA GINGEP 14.pdf
solo gestori archivio
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.45 MB
Formato
Adobe PDF
|
1.45 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
